SPEAKERS
Jennifer R. Allen, Ph.D., Director Medicinal Chemistry, Amgen
Steven W. Andrews, Ph.D., Associate Director, Drug Discovery, Array BioPharma, Inc.
Ottavio Arancio, M.D., Ph.D., Associate Professor, Department of Pathology and Cell Biology & The Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University
Corinne E. Augelli-Szafran, Ph.D., Director, Laboratory for Experimental Alzheimer Drugs (LEAD), Brigham and Women's Hospital, Center for Neurologic Diseases and Harvard Medical School, Department of Neurology
Jonathan M. Barasch, M.D., Ph.D., Associate Professor of Medicine, Associate Professor of Anatomy and Cell Biology, Columbia University Medical Center
Ed Bilsky, Ph.D., Professor of Pharmacology, COM; Director, Center of Excellence in the Neurosciences, University of New England
Lauren Black, Ph.D., Senior Scientific Advisor, Charles River Laboratories
Eric Blomme, DVM, Ph.D., DACVP, Senior Project Leader, Abbott Laboratories
Thomas Bocan, Ph.D., Senior Director & Head, BioImaging Center, Pfizer Global Research & Development, Pfizer, Inc.
Joseph Bonventre, Ph.D., Professor of Medicine, Harvard Medical School, and Chief, Renal Division, Brigham and Women's Hospital
Kim L. R. Brouwer, Pharm.D., Ph.D., Chair, Division of Pharmacotherapy and Experimental Therapeutics, The University of North Carolina at Chapel Hill
Lindsay H. Burns, Director, Pre-Clinical Research, Pain Therapeutics, Inc.
Zhou-Feng Chen, Ph.D., Associate Professor, Washington University Pain Center, Departments of Anesthesiology, Psychiatry & Developmental Biology, Washington University School of Medicine
Carol A. Colton, Ph.D., Professor, Neurology, Duke University
David Cook, Ph.D., Associate Director, Pharmacology and Toxcicology, Astra ZenecaR&D
Elizabeth A. Davenport, Ph.D., Manager, Cell-Based Assay Development, Department of Biological Reagents and Assay Development, Glaxo Smith Kline
Anthony Davies, Ph.D., Director, Trinity HCA, Department of Clinical Medicine, Trinity College Dublin
Prasad Devarajan, M.D., Professor of Pediatrics and Developmental Biology, University of Cincinnati College of Medicine
Scott Diamond, Ph.D., Founding Director, Penn Center for Molecular Discovery, E. Humphrey Chair of Chemical and Biomolecular Engineering, University of Pennsylvania
Dolo Diaz, Ph.D., DABT, Scientist, Investigative Safety Assessment, Genentech, Inc.
Lakshmi Devi, Ph.D., Professor, Pharmacology and Systems Therapeutics, Professor, Psychiatry; Mount Sinai
Jean-Cosme Dodart, Ph.D., Director, Mouse NeuroBehavior Core, Harvard NeuroDiscovery Center, Harvard Medical School
Angela X. Dunne, BSc, MSc, Principal Scientist, GlaxoSmithKline
Noël Dybdal, Ph.D., D.V.M., Associate Director, Principal Scientist, Safety Assessment, Genentech, Inc.
Gül Erdemli, M.D., Ph.D., Head of Ion Channel Group, Lead Finding Platform, Novartis Institute for Biomedical Research
Timothy A. Esbenshade, Sr. Group Leader, Associate Fellow, Neuroscience Research, Abbott Laboratories
John T. Farrar, M.D. ,M.S.C.E., Ph.D., Assistant Professor & Senior Scholar, Departments of Biostatistics and Epidemiology, Neurology, and Anesthesiology, University of Pennsylvania
Thomas Force, M.D., Professor of Medicine and Clinical Director of the Center for Translational Medicine, Thomas Jefferson University
Stephen Furlong Ph.D., Safety Science Lead, U.S., Patient Safety, AstraZeneca
Gary Gintant, Ph.D., Senior Group Leader, Department of Integrative Pharmacology, Global Pharmaceutical Research & Development, Abbott Laboratories
Ilya Glezerman, M.D., Assistant Attending Physician, Renal Service, Memorial Hospital for Cancer and Allied Diseases
Jerry D. Glickson, Ph.D., Professor and Director, Molecular Imaging, Department of Radiology, University of Pennsylvania School of Medicine
Peggy Guzzie-Peck, Ph.D., DABT, Vice President, Head of Toxicology, Pathology & LAM, Johnson & Johnson, Pharma R&D
James Hecker, Ph.D., M.D., Assistant Professor, Anesthesia and Critical Care, University of PennsylvaniaAdam W.
Hendricson, Ph.D., Research Investigator, Lead Evaluation and Ion Channels, Bristol-Myers Squibb Co.
Andrew M. Herzenberg, M.D., FRCPC, Assistant Professor of Pathology, Department of Pathology , Consultant Nephropathologist, University Health Network and University of Toronto
Tony Ho, M.D., Senior Director, Clinical Neuroscience & Ophthalmology, Merck Research Laboratories
Peter Hodder, Ph.D., Senior Director, Lead Identification, Translational Research Institute, The Scripps Research Institute
Zhiyuan Hu, Ph.D., Research Scientist, Institute for Systems Biology
Craig T. January, M.D., Ph.D., Professor, Medicine and Physiology, Division of Cardiovascular Medicine, University of Wisconsin-Madison
Michael F. Jarvis, Ph.D., Vowiler Research Fellow, Associate Director, Neuroscience, Global Pharmaceutical Research & Development , Abbott
Linda Jett, MSN, Clinical Director, Drug Development, DARA BioSciences
Douglas S. Johnson, Ph.D., Senior Principal Scientist, Medicinal Chemistry, Pfizer Global Research & Development
Eric Johnson, Ph.D., Senior Research Fellow, Automated Biotechnology, Merck Research Laboratories
Shama M. Kajiji, Ph.D., MBA, Director, Pipeline and Portfolio Management, Merck & Co.
Amit S. Kalgutkar, Ph.D., Research Fellow, Pharmacokinetics, Dynamics and Metabolism Department, Pfizer Global R&D
Francis Kalush, Ph.D., Network Leader, Diagnostics, Office of the Center Director, Center for Devices and Radiological Health, FDA
Timothy J. Kamp, M.D., Ph.D., Professor of Medicine and Physiology and Director, Stem Cell and Regenerative
Daniel B. Kassel, Ph.D., Vice President, Analytical Sciences and DMPK, Takeda San Diego, Inc.
Terry Kenakin, Ph.D., Director, Biological Reagents and Assay Development, GlaxoSmithKline Research and Development, Research Triangle Park, NC USA
Albert M. Kim, M.D., Ph.D., Senior Translational Medicine Expert, Cardiac Electrophysiology/Cardiovascular Discovery, Novartis Institutes for BioMedical Research, Inc.
Amy Kim, Ph.D., Senior Scientist/Toxicologist, Department of Safety Assessment, Genentech, Inc.
Fred King, Ph.D., Research Investigator, The Novartis Institute of Biomedical Research
Rainer Kneuer, Ph.D., Research Investigator II, Lab Head, Tracer Development, Novartis Institutes for Biomedical Research, Inc.
Hisataka Kobayashi, M.D., Ph.D., Chief Scientist, Molecular Imaging Program, NCI/NIH
Kenneth S. Korach, Ph.D., Director, Environmental Disease and Medicine Program, Chief, Laboratory of Reproductive and Developmental Toxicology, NIEHS/NIH
Thomas Krucker, Ph.D., Head, Molecular Imaging, Novartis Institute for Biomedical Research
Priya Kunapuli, Ph.D., Director, In Vitro Sciences, BRSO, Merck Research Laboratories
Richard Lewis, Ph.D., CSO, Research & Development, Xenome Ltd.
Michael A. Letavic, Ph.D., Research Fellow, Neuroscience, Johnson & Johnson PRD, L.L.C.
Michael Liebman, Ph.D., President/Managing Director, Management, Strategic Medicine, Inc.
Barry London, M.D., Ph.D., Professor of Medicine and Chief, Division of Cardiology, University of Pittsburgh School of Medicine
Charles Lunn, Ph.D., Research Fellow, New Lead Discovery, Merck Research Laboratories
José E. Manautou, Ph.D., Associate Professor of Toxicology, Department of Pharmaceutical Sciences, University of Connecticut
Pat Mantyh, Ph.D., J.D., Department of Pharmacology, University of Arizona College of Medicine
William B. Mattes, Ph.D., DABT, Independent Consultant, PharmPoint Consulting
Bruce A. Molitoris, M.D., Director, Division of Nephrology and Professor of Medicine, Indiana University
Colleen Niswender, Ph.D., Research Assistant Professor, Pharmacology, Vanderbilt University
Richard R. Neubig, M.D.,Ph.D., Professor of Pharmacology; Associate Professor of Internal Medicine; Biophysics Research Division - Associated Faculty Medicinal Chemistry IDP; Center for Chemical Genomics, Associate Director, University of Michigan
Emile F. Nuwaysir, Ph.D., Vice President and Chief Operating Officer, Cellular Dynamics International
Christopher J. O’Donnell, Ph.D., Senior Director, Neuroscience Chemistry, Pfizer Inc., Groton, CT
Stacey Oppenheimer, Ph.D., Senior Scientist, Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global Research and Development, Pfizer, Inc.
Michelle Palmer, Ph.D., Director of Screening, Chemical Biology Platform, Broad Institute of Harvard and MIT
Holger Patzke, Ph.D, Principal Scientist, EnVivo Pharmaceuticals
Gary Peltz, M.D., Ph.D., Professor, Anesthesia, Stanford University
Sanjay W. Pimplikar, Ph.D., Assistant Staff, Department of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation
Stefan Platz, Ph.D., D.V.M., Head of Toxicology/Pathology, F. Hoffmann-La Roche Ltd.
Valerica Raicu, Ph.D., Associate Professor, Physics; Biological Sciences, University of Wisconsin
William J. Ray, Ph.D.,Director, Neurology, Merck Research Laboratories
Arie Regev, M.D., Hepatology Consultant and Chair, Liver and GI Safety Committee, Global Patient Safety, Eli Lilly and Company
Cornelia Reininger, M.D. Ph.D., Director, Global Clinical Development, Bayer Health Care Pharmaceuticals
Ivan Rusyn, M.D., Ph.D., Associate Professor of Environmental Science and Engineering, University of North Carolina
Guy Salama, Ph.D., Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine
William Salminen Ph.D., DABT, Director of the Center for Hepatotoxicity, U.S. FDA National Center for Toxicological Research
Dany Salvail, Ph.D., Director, Pharmacology, Cardiac Safety and Toxicity, IPS Therapeutique, Inc.
Susanta Sarkar, Ph.D., Director, Clinical Imaging, Medicines Development, Oncology R&D , GlaxoSmithKline
Daniel G. Sipes, Director, Advanced Automation Technologies, Genomics Institute of the Novartis Research Foundation
Clay Scott, Ph.D., Associate Director, Lead Generation, AstraZeneca Pharmaceuticals
Larry A. Sklar, Ph.D., Distinguished Regents Professor of Pathology; Associate Director of Basic Research, University of New Mexico Cancer Center; Director, University of New Mexico Center for Molecular Discovery
Mark A. Smith, Ph.D., Professor of Pathology, Case Western Reserve
Sam Sofer, Ph.D., PE, President, solmedx
Ramana Sonty, Ph.D., Director, Neuroscience Program, Wyeth Pharmaceuticals
Steven L. Stice, Ph.D., Professor, Director, Regenerative Bioscience Center, University of Georgia
Cyrille Sur, Ph.D., Director, Molecular Imaging, Merck Research Laboratories
William Sun, Ph.D., Group Leader, Stem Cell Technology, Experimental Therapeutics Centre, A*STAR
Matthew Todd, Ph.D., Research Fellow, Team Leader, Lead Generation Biology , Johnson & Johnson, PR&D
Richard Torres, Ph.D., Senior Staff Scientist, Pain Therapeutics, Regeneron Pharmaceuticals, Inc.
Linda VanEldik, Ph.D., Director, Sanders-Brown Center on Aging, and Professor, Dept Anatomy and Neurobiology, University of Kentucky, Lexington KY
Kenneth Verburg, Ph.D., Vice President, Development Head, Pfizer’s Pain Portfolio, Pfizer, Inc.
Jonathan Violin, Ph.D., Co-Founder, Director of Biology, Trevena Inc.
Victor Uebele, Ph.D., Senior Research Biologist, Depression & Circadian Disorders, Merck Research Laboratories
Hong Wan, Ph.D., Director, Translational Medicine, Pfizer, Inc.
Jan Wahlstrom, Ph.D., Senior Scientist, Pharmacokinetics and Drug Metabolism, Amgen, Inc.
Tetsuro Wakatsuki, Ph.D., Assistant Professor of Physiology, Biotechnology and Bioengineering Center, Medical College of Wisconsin
Chris L. Waller, Ph.D., Senior Director, HealthCare Informatics, Medical Business Technology, Pfizer, Inc.
Paul Watkins, M.D., Director, Hamner-UNC Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill
John Watson, Ph.D., Lead Investigator, BMS
Stephen G. Waxman, M.D., Ph.D., Bridget Marie Flaherty Professor of Neurology, Neurobiology, and Pharmacology; Director, Center for Neuroscience & Regeneration/Rehabilitation Research, Yale University School of Medicine
Charles David Weaver, Ph.D., Director, Vanderbilt Institute of Chemical Biology's High-Throughput Screening, Co-director, Vanderbilt's Molecular Library Screening Center, Research Associate Professor, Pharmacology, Vanderbilt University
Yvonne Will, Ph.D., Associate Research Fellow, Compound Safety Prediction, Pfizer Global R&D
Hong Xin, Ph.D., Senior Scientist, Lead Generation Biology, Johnson & Johnson, PRD
Wei Zheng, Ph.D., Group Leader, NIH Chemical Genomics Center, National Human Genome Research Institute, National Institutes of Health